ZIM Laboratories Limited (NSE:ZIMLAB)
India · Delayed Price · Currency is INR 125.50
-2.52 (-1.97%)
Sep 4, 2026, 3:29 PM IST
ZIM Laboratories Market Cap
ZIM Laboratories has a market cap or net worth of 6.72 billion as of September 4, 2026. Its market cap has increased by 82.17% in one year.
Market Cap
6.72B
Enterprise Value
7.59B
Revenue
3.97B
Ranking
n/a
PE Ratio
181.89
Stock Price
125.50
ChartMarket Cap Chart
Since June 11, 2018, ZIM Laboratories's market cap has increased from 1.68B to 6.72B, an increase of 299.78%. That is a compound annual growth rate of 18.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 6.72B | 91.89% |
| Dec 31, 2025 | 3.50B | -33.11% |
| Dec 31, 2024 | 5.24B | -6.72% |
| Dec 29, 2023 | 5.62B | 18.57% |
| Dec 30, 2022 | 4.74B | 146.60% |
| Dec 31, 2021 | 1.92B | 31.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Windlas Biotech | 23.24B |
| Sakar Healthcare | 22.56B |
| Beta Drugs | 22.39B |
| Jagsonpal Pharmaceuticals | 15.96B |
| Sigachi Industries | 13.27B |
| Anlon Healthcare | 8.33B |
| Amanta Healthcare | 7.53B |
| Bafna Pharmaceuticals | 7.00B |